Engineered microorganisms play a significant role in industrial biotechnology, contributing to fields such as biofuels, sustainable chemicals, and therapeutic compounds.
Despite their benefits, there are ongoing concerns regarding potential unintended consequences associated with their use.
The latest advancements in CRISPR technology introduce new safeguards designed to address these safety concerns, potentially improving the management of these engineered microbes.